O. Craven

421 total citations
15 papers, 334 citations indexed

About

O. Craven is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Dermatology. According to data from OpenAlex, O. Craven has authored 15 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Dermatology. Recurrent topics in O. Craven's work include Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (5 papers) and Palliative Care and End-of-Life Issues (4 papers). O. Craven is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Cancer Treatment and Pharmacology (5 papers) and Palliative Care and End-of-Life Issues (4 papers). O. Craven collaborates with scholars based in United Kingdom, United States and Hong Kong. O. Craven's co-authors include Karen Luker, Alex Molassiotis, Mark Saunders, S. Susnerwala, Kinta Beaver, David Jones, Sarah Brearley, R. Swindell, Gary Witham and Andrew Wardley and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Journal of Clinical Nursing.

In The Last Decade

O. Craven

15 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
O. Craven United Kingdom	8	160	146	131	55	32	15	334
M. Sage United Kingdom	3	175 1.1×	86 0.6×	124 0.9×	83 1.5×	23 0.7×	7	319
Nicola J Davies United Kingdom	6	289 1.8×	114 0.8×	101 0.8×	103 1.9×	8 0.3×	14	426
Charmaine Cummings United States	9	171 1.1×	352 2.4×	63 0.5×	215 3.9×	16 0.5×	14	538
Miklos Auber United States	8	127 0.8×	244 1.7×	79 0.6×	132 2.4×	5 0.2×	23	414
Oluwaseyifunmi Andi Agbejule Australia	10	297 1.9×	183 1.3×	81 0.6×	130 2.4×	8 0.3×	20	505
V. Pedersen United Kingdom	7	174 1.1×	87 0.6×	84 0.6×	52 0.9×	9 0.3×	13	363
Jeong Hye Kim South Korea	11	125 0.8×	55 0.4×	123 0.9×	17 0.3×	5 0.2×	59	387
Deena R. Loeffler United States	6	256 1.6×	145 1.0×	75 0.6×	123 2.2×	8 0.3×	8	490
Lauren Nisotel United States	4	127 0.8×	109 0.7×	126 1.0×	133 2.4×	231 7.2×	12	494
Mervi Siekkinen Finland	9	119 0.7×	97 0.7×	194 1.5×	33 0.6×	10 0.3×	18	338

Countries citing papers authored by O. Craven

Since Specialization

Citations

This map shows the geographic impact of O. Craven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Craven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Craven more than expected).

Fields of papers citing papers by O. Craven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Craven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Craven. The network helps show where O. Craven may publish in the future.

Co-authorship network of co-authors of O. Craven

This figure shows the co-authorship network connecting the top 25 collaborators of O. Craven. A scholar is included among the top collaborators of O. Craven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Craven. O. Craven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Oakley, Catherine, et al.. (2016). ecancermedicalscience. ecancermedicalscience. 4. 177–177. 5 indexed citations

Craven, O., et al.. (2013). Is a nurse-led telephone intervention a viable alternative to nurse-led home care and standard care for patients receiving oral capecitabine? Results from a large prospective audit in patients with colorectal cancer. European Journal of Cancer Care. 22(3). 413–419. 38 indexed citations

Ellis, Jackie, Sarah Brearley, O. Craven, & Alex Molassiotis. (2012). Understanding the Symptom Experience of Patients with Gastrointestinal Cancers in the First Year Following Diagnosis: Findings from a Qualitative Longitudinal Study. Journal of Gastrointestinal Cancer. 44(1). 60–67. 14 indexed citations

Beaver, Kinta, Malcolm Campbell, O. Craven, et al.. (2009). Colorectal cancer patients’ attitudes towards involvement in decision making. Health Expectations. 12(1). 27–37. 25 indexed citations

Brearley, Sarah, et al.. (2009). Clinical features of oral chemotherapy: results of a longitudinal prospective study of breast and colorectal cancer patients receiving capecitabine in the UK. European Journal of Cancer Care. 19(4). 425–433. 5 indexed citations

Brearley, Sarah, O. Craven, Brenda Wilson, Lisa Brunton, & Alex Molassiotis. (2009). 4166 Gastro-intestinal cancer patients: how they perceive and cope with disease and treatment-related symptoms over a 12-month period. European Journal of Cancer Supplements. 7(2). 234–234. 1 indexed citations

Molassiotis, Alex, Sarah Brearley, Mark Saunders, et al.. (2009). Effectiveness of a Home Care Nursing Program in the Symptom Management of Patients With Colorectal and Breast Cancer Receiving Oral Chemotherapy: A Randomized, Controlled Trial. Journal of Clinical Oncology. 27(36). 6191–6198. 115 indexed citations

Valle, Juan W., et al.. (2008). Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (SCOUT) in metastatic colorectal cancer. British Journal of Cancer. 99(4). 577–583. 5 indexed citations

Valle, Juan W., et al.. (2007). Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a Phase I study. British Journal of Cancer. 96(1). 38–43. 12 indexed citations

10.

Beaver, Kinta, O. Craven, Gary Witham, et al.. (2007). Patient participation in decision making: views of health professionals caring for people with colorectal cancer. Journal of Clinical Nursing. 16(4). 725–733. 35 indexed citations

11.

Valle, Juan W., et al.. (2007). Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (LV) (SCOUT) in patients with advanced colorectal cancer (ACRC): A phase I/II study. Journal of Clinical Oncology. 25(18_suppl). 4084–4084. 2 indexed citations

12.

Beaver, Kinta, David Jones, S. Susnerwala, et al.. (2005). Exploring the decision‐making preferences of people with colorectal cancer. Health Expectations. 8(2). 103–113. 67 indexed citations

13.

Beaver, Kinta, Karen Luker, Daniel Jones, et al.. (2003). 1138 The treatment decision-making preferences of people with colorectal cancer. European Journal of Cancer Supplements. 1(5). S345–S346. 1 indexed citations

14.

Craven, O.. (2001). Screening for colorectal cancer using the faecal occult blood test: a critical literature review. European Journal of Oncology Nursing. 5(4). 234–243. 7 indexed citations

15.

Craven, O.. (2000). Palliative care provision and its impact on psychological morbidity in cancer patients. International Journal of Palliative Nursing. 6(10). 501–507. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact